vs
CANTALOUPE, INC.（CTLP）与RHYTHM PHARMACEUTICALS, INC.（RYTM）财务数据对比。点击上方公司名可切换其他公司
CANTALOUPE, INC.的季度营收约是RHYTHM PHARMACEUTICALS, INC.的1.4倍（$78.7M vs $57.3M），CANTALOUPE, INC.净利率更高（-0.1% vs -83.0%，领先82.9%），RHYTHM PHARMACEUTICALS, INC.同比增速更快（36.9% vs 6.8%），过去两年RHYTHM PHARMACEUTICALS, INC.的营收复合增速更高（48.5% vs 7.7%）
坎塔卢波（原美国技术公司）是一家美国科技企业，核心业务为ePort无现金支付受理技术，依托持专利的PCI合规ePort Connect服务开展运营。该服务可通过无线方式为消费者提供信用卡、借记卡以及Apple Pay、Google Pay等NFC钱包支付选项，同时为运营商提供遥测与机器间通信服务，ePort技术主要应用于...
Rhythm Pharmaceuticals是一家专注于罕见病领域的生物制药企业，主要开发和商业化针对罕见遗传性肥胖症的靶向疗法，覆盖POMC缺陷、LEPR缺陷、巴德-毕德氏综合征等适应症，服务北美、欧洲地区缺少有效治疗方案的患者群体。
CTLP vs RYTM — 直观对比
营收规模更大
CTLP
是对方的1.4倍
$57.3M
营收增速更快
RYTM
高出30.1%
6.8%
净利率更高
CTLP
高出82.9%
-83.0%
两年增速更快
RYTM
近两年复合增速
7.7%
损益表 — Q2 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $78.7M | $57.3M |
| 净利润 | $-70.0K | $-47.5M |
| 毛利率 | — | 91.6% |
| 营业利润率 | 2.0% | -82.2% |
| 净利率 | -0.1% | -83.0% |
| 营收同比 | 6.8% | 36.9% |
| 净利润同比 | -101.4% | -9.6% |
| 每股收益（稀释后） | $0.00 | $-0.73 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CTLPRYTM
| Q4 25 | $78.7M | $57.3M | ||
| Q3 25 | $80.9M | $51.3M | ||
| Q2 25 | $82.6M | $48.5M | ||
| Q1 25 | $75.4M | $32.7M | ||
| Q4 24 | $73.7M | $41.8M | ||
| Q3 24 | $70.8M | $33.3M | ||
| Q2 24 | $72.7M | $29.1M | ||
| Q1 24 | $67.9M | $26.0M |
净利润CTLPRYTM
| Q4 25 | $-70.0K | $-47.5M | ||
| Q3 25 | $-919.0K | $-52.9M | ||
| Q2 25 | $6.8M | $-46.6M | ||
| Q1 25 | $49.2M | $-49.5M | ||
| Q4 24 | $5.0M | $-43.3M | ||
| Q3 24 | $3.6M | $-43.6M | ||
| Q2 24 | $2.2M | $-32.3M | ||
| Q1 24 | $4.7M | $-141.4M |
毛利率CTLPRYTM
| Q4 25 | — | 91.6% | ||
| Q3 25 | — | 89.3% | ||
| Q2 25 | — | 88.6% | ||
| Q1 25 | — | 88.8% | ||
| Q4 24 | — | 90.9% | ||
| Q3 24 | — | 88.5% | ||
| Q2 24 | — | 89.9% | ||
| Q1 24 | 39.6% | 89.2% |
营业利润率CTLPRYTM
| Q4 25 | 2.0% | -82.2% | ||
| Q3 25 | 2.0% | -102.6% | ||
| Q2 25 | 6.3% | -93.4% | ||
| Q1 25 | 9.1% | -143.7% | ||
| Q4 24 | 8.4% | -98.6% | ||
| Q3 24 | 5.8% | -132.0% | ||
| Q2 24 | 4.9% | -139.2% | ||
| Q1 24 | 6.3% | -538.7% |
净利率CTLPRYTM
| Q4 25 | -0.1% | -83.0% | ||
| Q3 25 | -1.1% | -103.1% | ||
| Q2 25 | 8.3% | -96.1% | ||
| Q1 25 | 65.2% | -151.4% | ||
| Q4 24 | 6.7% | -103.6% | ||
| Q3 24 | 5.0% | -131.2% | ||
| Q2 24 | 3.0% | -110.9% | ||
| Q1 24 | 6.9% | -544.4% |
每股收益（稀释后）CTLPRYTM
| Q4 25 | $0.00 | $-0.73 | ||
| Q3 25 | $-0.02 | $-0.82 | ||
| Q2 25 | $0.10 | $-0.75 | ||
| Q1 25 | $0.65 | $-0.81 | ||
| Q4 24 | $0.07 | $-0.71 | ||
| Q3 24 | $0.04 | $-0.73 | ||
| Q2 24 | $0.03 | $-0.55 | ||
| Q1 24 | $0.06 | $-2.35 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $53.0M | $388.9M |
| 总债务越低越好 | $37.7M | — |
| 股东权益账面价值 | $252.5M | $139.1M |
| 总资产 | $381.9M | $480.2M |
| 负债/权益比越低杠杆越低 | 0.15× | — |
8季度趋势，按日历期对齐
现金及短期投资CTLPRYTM
| Q4 25 | $53.0M | $388.9M | ||
| Q3 25 | $55.0M | $416.1M | ||
| Q2 25 | $51.1M | $291.0M | ||
| Q1 25 | $46.3M | $314.5M | ||
| Q4 24 | $27.7M | $320.6M | ||
| Q3 24 | $33.1M | $298.4M | ||
| Q2 24 | $58.9M | $319.1M | ||
| Q1 24 | $50.2M | $201.2M |
总债务CTLPRYTM
| Q4 25 | $37.7M | — | ||
| Q3 25 | $38.3M | — | ||
| Q2 25 | $38.7M | — | ||
| Q1 25 | $39.2M | — | ||
| Q4 24 | $37.0M | — | ||
| Q3 24 | $37.3M | — | ||
| Q2 24 | $37.5M | — | ||
| Q1 24 | $38.1M | — |
股东权益CTLPRYTM
| Q4 25 | $252.5M | $139.1M | ||
| Q3 25 | $251.8M | $148.8M | ||
| Q2 25 | $251.0M | $-11.9M | ||
| Q1 25 | $240.7M | $18.9M | ||
| Q4 24 | $190.1M | $21.7M | ||
| Q3 24 | $186.2M | $11.2M | ||
| Q2 24 | $181.7M | $39.3M | ||
| Q1 24 | $178.8M | $61.6M |
总资产CTLPRYTM
| Q4 25 | $381.9M | $480.2M | ||
| Q3 25 | $389.5M | $506.9M | ||
| Q2 25 | $381.9M | $372.7M | ||
| Q1 25 | $370.5M | $386.7M | ||
| Q4 24 | $303.0M | $392.3M | ||
| Q3 24 | $312.1M | $363.6M | ||
| Q2 24 | $335.6M | $381.8M | ||
| Q1 24 | $319.9M | $258.7M |
负债/权益比CTLPRYTM
| Q4 25 | 0.15× | — | ||
| Q3 25 | 0.15× | — | ||
| Q2 25 | 0.15× | — | ||
| Q1 25 | 0.16× | — | ||
| Q4 24 | 0.19× | — | ||
| Q3 24 | 0.20× | — | ||
| Q2 24 | 0.21× | — | ||
| Q1 24 | 0.21× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $3.1M | $-25.4M |
| 自由现金流经营现金流 - 资本支出 | $-614.0K | — |
| 自由现金流率自由现金流/营收 | -0.8% | — |
| 资本支出强度资本支出/营收 | 4.8% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $25.8M | — |
8季度趋势，按日历期对齐
经营现金流CTLPRYTM
| Q4 25 | $3.1M | $-25.4M | ||
| Q3 25 | $7.0M | $-26.6M | ||
| Q2 25 | $9.4M | $-23.3M | ||
| Q1 25 | $22.4M | $-40.4M | ||
| Q4 24 | $522.0K | $-18.8M | ||
| Q3 24 | $-12.0M | $-25.2M | ||
| Q2 24 | $14.3M | $-29.1M | ||
| Q1 24 | $14.7M | $-40.7M |
自由现金流CTLPRYTM
| Q4 25 | $-614.0K | — | ||
| Q3 25 | $3.5M | — | ||
| Q2 25 | $4.3M | — | ||
| Q1 25 | $18.6M | — | ||
| Q4 24 | $-3.8M | — | ||
| Q3 24 | $-15.8M | — | ||
| Q2 24 | $8.5M | — | ||
| Q1 24 | $11.4M | — |
自由现金流率CTLPRYTM
| Q4 25 | -0.8% | — | ||
| Q3 25 | 4.4% | — | ||
| Q2 25 | 5.3% | — | ||
| Q1 25 | 24.6% | — | ||
| Q4 24 | -5.1% | — | ||
| Q3 24 | -22.3% | — | ||
| Q2 24 | 11.7% | — | ||
| Q1 24 | 16.9% | — |
资本支出强度CTLPRYTM
| Q4 25 | 4.8% | — | ||
| Q3 25 | 4.2% | — | ||
| Q2 25 | 6.2% | — | ||
| Q1 25 | 5.1% | — | ||
| Q4 24 | 5.8% | — | ||
| Q3 24 | 5.4% | — | ||
| Q2 24 | 7.9% | — | ||
| Q1 24 | 4.8% | — |
现金转化率CTLPRYTM
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 1.38× | — | ||
| Q1 25 | 0.46× | — | ||
| Q4 24 | 0.10× | — | ||
| Q3 24 | -3.36× | — | ||
| Q2 24 | 6.47× | — | ||
| Q1 24 | 3.16× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CTLP
| Transaction Processing | $47.9M | 61% |
| Subscription Revenue | $21.8M | 28% |
| Products | $9.0M | 11% |
RYTM
暂无分部数据
